Omikron as a killjoy
Monthly report november 2021
Global stock markets started November with the momentum of a positive reporting season in the third quarter. Statements made by the US Federal Reserve in the course of the month regarding a gradual reduction in bond purchases and possible earlier interest rate steps have also been anticipated by the market. The rapidly rising inflation as part of the economic recovery is seen as a danger, but many market participants still see this as a temporary phenomenon.
Shortly before the end of the month, the Covid-19 pandemic has then again become the big spoiler: The newly discovered virus variant Omikron brought the markets to their knees and caused volatility to rise sharply. Travel restrictions, further supply and personnel bottlenecks and possible lockdowns have spoiled investors’ mood.
But see for yourself:
Book an initial consultation directly now
Gladly in person or digitally, conveniently and easily from home. Conserving resources without the expense of travel.
More articles on asset management
Volatile summer Monthly report August 2022 The stock markets got off to a mostly positive start in August, carrying over the momentum from the previous month. Nevertheless, many market participants remained on the sidelines and watched...
We have remained true to our strategy Monthly report July 2022 In July, the financial markets again had to contend with various challenges, with galloping inflation worldwide continuing to be the market-dominating issue. After initial...
Quarterly Report Q2/2022 Review In the first quarter, the start of the Russian attack on Ukraine led the markets down, and the second quarter was not spared from a downward demolition. However, the latter was more owed to the negative overall...